4//SEC Filing
ENANTA PHARMACEUTICALS INC 4
Accession 0001012975-14-000111
$ENTACIK 0001177648operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:23 PM ET
Size
27.3 KB
Accession
0001012975-14-000111
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2014-02-21$40.00/sh−5,034$201,360→ 1,606,272 total - Sale
Common Stock
2014-02-24$39.51/sh−8,130$321,211→ 380,487 total - Sale
Common Stock
2014-02-21$40.00/sh−1,628$65,120→ 519,350 total - Sale
Common Stock
2014-02-21$40.00/sh−1,218$48,720→ 388,617 total - Sale
Common Stock
2014-02-24$39.51/sh−10,865$429,269→ 508,485 total - Sale
Common Stock
2014-02-24$39.51/sh−33,602$1,327,591→ 1,572,670 total
Footnotes (4)
- [F1]The shares are directly held by TVM Medical Ventures GmbH & Co. KG ("Medical Ventures"), the general partner of which is TVM Capital GmbH ("TVM Capital"), for which Alexandra Goll ("Goll"), one member of the investment committee of TVM Capital, shares voting and investment authority over the shares held by Medical Ventures with the other member of the investment committee. Each of TVM Capital and Goll disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- [F2]The shares are directly held by TVM IV GmbH & Co. KG ("TVM IV"), the managing limited partner of which is TVM IV Management GmbH & Co. KG ("TVM IV Management"), for which Goll, one member of the investment committee of TVM IV Management, shares voting and investment authority over the shares held by TVM IV with the other members of the investment committee. Each of TVM IV Management and Goll disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- [F3]The shares are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which Hubert Birner ("Birner"), Stefan Fischer ("Fischer") and Goll, each a member of the investment committee of TVM V Management, shares voting and investment authority over the shares held by TVM V. Each of TVM V Management, Birner, Fischer and Goll disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $40.00, inclusive. Each Reporting Person undertakes to provide to Enanta Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeoperating
Related Parties
1- filerCIK 0001177648
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:23 PM ET
- Size
- 27.3 KB